Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies.

MLA

Mariampillai, Kubéraka, et al. “Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies.” JAMA Neurology, vol. 75, no. 12, Dec. 2018, pp. 1528–37. EBSCOhost, https://doi.org/10.1001/jamaneurol.2018.2598.

APA

Mariampillai, K., Granger, B., Amelin, D., Guiguet, M., Hachulla, E., Maurier, F., Meyer, A., Tohmé, A., Charuel, J.-L., Musset, L., Allenbach, Y., & Benveniste, O. (2018). Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies. JAMA Neurology, 75(12), 1528–1537. https://doi.org/10.1001/jamaneurol.2018.2598

Chicago

Mariampillai, Kubéraka, Benjamin Granger, Damien Amelin, Marguerite Guiguet, Eric Hachulla, François Maurier, Alain Meyer, et al. 2018. “Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies.” JAMA Neurology 75 (12): 1528–37. doi:10.1001/jamaneurol.2018.2598.